Results
1
Stocks with high levels of insider buying the past 3 months and good analyst coverage.
1 companies
Biomark Diagnostics
Market Cap: €34.9m
Develops early-stage cancer diagnostic technology platform to detect and treat cancer.
20B
€0.31
7D
11.4%
1Y
134.6%